研究者業績

亀山 俊樹

Toshiki Kameyama

基本情報

所属
藤田医科大学 医学部 生理学 I 准教授
学位
博士(理学)(名古屋大学)

研究者番号
60298544
ORCID ID
 https://orcid.org/0000-0002-7348-7572
J-GLOBAL ID
200901005394038415
researchmap会員ID
1000226784

外部リンク

神経細胞の分化機構を研究しています。

 


学歴

 2

委員歴

 1

論文

 30
  • Miho Kawata, Yu Kodani, Mahito Ohkuma, Ei-Ichi Miyachi, Yoko S Kaneko, Akira Nakashima, Hidetaka Suga, Toshiki Kameyama, Kanako Saito, Hiroshi Nagasaki
    PloS one 17(11) e0276694 2022年11月  査読有り
    The hypothalamus is comprised of heterogenous cell populations and includes highly complex neural circuits that regulate the autonomic nerve system. Its dysfunction therefore results in severe endocrine disorders. Although recent experiments have been conducted for in vitro organogenesis of hypothalamic neurons from embryonic stem (ES) or induced pluripotent stem (iPS) cells, whether these stem cell-derived hypothalamic neurons can be useful for regenerative medicine remains unclear. We therefore performed orthotopic transplantation of mouse ES cell (mESC)-derived hypothalamic neurons into adult mouse brains. We generated electrophysiologically functional hypothalamic neurons from mESCs and transplanted them into the supraoptic nucleus of mice. Grafts extended their axons along hypothalamic nerve bundles in host brain, and some of them even projected into the posterior pituitary (PPit), which consists of distal axons of the magnocellular neurons located in hypothalamic supraoptic and paraventricular nuclei. The axonal projections to the PPit were not observed when the mESC-derived hypothalamic neurons were ectopically transplanted into the substantia nigra reticular part. These findings suggest that our stem cell-based orthotopic transplantation approach might contribute to the establishment of regenerative medicine for hypothalamic and pituitary disorders.
  • Yu Kodani, Miho Kawata, Hidetaka Suga, Takatoshi Kasai, Chikafumi Ozone, Mayu Sakakibara, Atsushi Kuwahara, Shiori Taga, Hiroshi Arima, Toshiki Kameyama, Kanako Saito, Akira Nakashima, Hiroshi Nagasaki
    Frontiers in Endocrinology 13 941166-941166 2022年7月12日  査読有り
    Human stem cell-derived organoid culture enables the in vitro analysis of the cellular function in three-dimensional aggregates mimicking native organs, and also provides a valuable source of specific cell types in the human body. We previously established organoid models of the hypothalamic-pituitary (HP) complex using human pluripotent stem cells. Although the models are suitable for investigating developmental and functional HP interactions, we consider that isolated pituitary cells are also useful for basic and translational research on the pituitary gland, such as stem cell biology and regenerative medicine. To develop a method for the purification of pituitary cells in HP organoids, we performed surface marker profiling of organoid cells derived from human induced pluripotent stem cells (iPSCs). Screening of 332 human cell surface markers and a subsequent immunohistochemical analysis identified epithelial cell adhesion molecule (EpCAM) as a surface marker of anterior pituitary cells, as well as their ectodermal precursors. EpCAM was not expressed on hypothalamic lineages; thus, anterior pituitary cells were successfully enriched by magnetic separation of EpCAM+ cells from iPSC-derived HP organoids. The enriched pituitary population contained functional corticotrophs and their progenitors; the former responded normally to a corticotropin-releasing hormone stimulus. Our findings would extend the applicability of organoid culture as a novel source of human anterior pituitary cells, including stem/progenitor cells and their endocrine descendants.
  • Yu Kodani, Miho Kawata, Hidetaka Suga, Yoko S Kaneko, Akira Nakashima, Toshiki Kameyama, Kanako Saito, Hiroshi Nagasaki
    eNeuro 2022年4月18日  査読有り
    Hypothalamic melanin-concentrating hormone (MCH) neurons are important regulators of multiple physiological processes, such as sleep, feeding, and memory. Despite the increasing interest in their neuronal functions, the molecular mechanism underlying MCH neuron development remains poorly understood. We report that a three-dimensional culture of mouse embryonic stem cells (mESCs) can generate hypothalamic-like tissues containing MCH-positive neurons, which reproduce morphologic maturation, neuronal connectivity, and neuropeptide/neurotransmitter phenotype of native MCH neurons. Using this in vitro system, we demonstrate that Hedgehog (Hh) signaling serves to produce major neurochemical subtypes of MCH neurons characterized by the presence or absence of cocaine- and amphetamine-regulated transcript (CART). Without exogenous Hh signals, mESCs initially differentiated into dorsal hypothalamic/prethalamic progenitors and finally into MCH+CART+ neurons through a specific intermediate progenitor state. Conversely, activation of the Hh pathway specified ventral hypothalamic progenitors that generate both MCH+CART- and MCH+CART+ neurons. These results suggest that in vivo MCH neurons may originate from multiple cell lineages that arise through early dorsoventral patterning of the hypothalamus. Additionally, we found that Hh signaling supports the differentiation of mESCs into orexin/hypocretin neurons, a well-defined cell group intermingled with MCH neurons in the lateral hypothalamic area (LHA). The present study highlights and improves the utility of mESC culture in the analysis of the developmental programs of specific hypothalamic cell types.Significance StatementA growing body of literature has revealed the importance of hypothalamic melanin-concentrating hormone (MCH) neurons in energy homeostasis and the cognitive function, but their developmental biology remains relatively unknown. To establish a new approach for addressing this issue, we tested the ability of an in vitro differentiation system of mouse embryonic stem cells (mESCs) to recapitulate the development of MCH neurons. The mESC culture robustly generated MCH-positive neurons resembling native neurons in several aspects and provided evidence that Hedgehog (Hh) signaling is a key factor to produce neurochemical subtypes of MCH neurons. Our results demonstrate the suitability of mESC culture as a platform to study the molecular mechanisms underlying the development of MCH neurons and possibly of other hypothalamic cell types.
  • Huey-Huey Chua, Toshiki Kameyama, Akila Mayeda, Te-Huei Yeh
    International journal of molecular sciences 23(5) 2022年2月24日  査読有り
    Tumor viruses gain control of cellular functions when they infect and transform host cells. Alternative splicing is one of the cellular processes exploited by tumor viruses to benefit viral replication and support oncogenesis. Epstein-Barr virus (EBV) participates in a number of cancers, as reported mostly in nasopharyngeal carcinoma (NPC) and Burkitt lymphoma (BL). Using RT-nested-PCR and Northern blot analysis in NPC and BL cells, here we demonstrate that EBV promotes specific alternative splicing of TSG101 pre-mRNA, which generates the TSG101∆154-1054 variant though the agency of its viral proteins, such as EBNA-1, Zta and Rta. The level of TSG101∆154-1054 is particularly enhanced upon EBV entry into the lytic cycle, increasing protein stability of TSG101 and causing the cumulative synthesis of EBV late lytic proteins, such as VCA and gp350/220. TSG101∆154-1054-mediated production of VCA and gp350/220 is blocked by the overexpression of a translational mutant of TSG101∆154-1054 or by the depletion of full-length TSG101, which is consistent with the known role of the TSG101∆154-1054 protein in stabilizing the TSG101 protein. NPC patients whose tumor tissues express TSG101∆154-1054 have high serum levels of anti-VCA antibodies and high levels of viral DNA in their tumors. Our findings highlight the functional importance of TSG101∆154-1054 in allowing full completion of the EBV lytic cycle to produce viral particles. We propose that targeting EBV-induced TSG101 alternative splicing has broad potential as a therapeutic to treat EBV-associated malignancies.
  • Otani, Yuta, Fujita, Ken-ichi, Kameyama, Toshiki, Mayeda, Akila
    International Journal of Molecular Sciences 22(12) 6519 2021年6月  査読有り責任著者
  • Kentaro Tsukamoto, Naoaki Shinzawa, Akito Kawai, Masahiro Suzuki, Hiroyasu Kidoya, Nobuyuki Takakura, Hisateru Yamaguchi, Toshiki Kameyama, Hidehito Inagaki, Hiroki Kurahashi, Yasuhiko Horiguchi, Yohei Doi
    Nature communications 11(1) 3571-3571 2020年7月16日  査読有り
    Pathogenic bacteria of the genus Bartonella can induce vasoproliferative lesions during infection. The underlying mechanisms are unclear, but involve secretion of an unidentified mitogenic factor. Here, we use functional transposon-mutant screening in Bartonella henselae to identify such factor as a pro-angiogenic autotransporter, called BafA. The passenger domain of BafA induces cell proliferation, tube formation and sprouting of microvessels, and drives angiogenesis in mice. BafA interacts with vascular endothelial growth factor (VEGF) receptor-2 and activates the downstream signaling pathway, suggesting that BafA functions as a VEGF analog. A BafA homolog from a related pathogen, Bartonella quintana, is also functional. Our work unveils the mechanistic basis of vasoproliferative lesions observed in bartonellosis, and we propose BafA as a key pathogenic factor contributing to bacterial spread and host adaptation.
  • Huey-Huey Chua, Toshiki Kameyama, Akila Mayeda, Te-Huei Yeh
    International Journal of Molecular Science 20(3) 773 2019年2月  査読有り
  • Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma, Kiyoko Yamamoto, Masamitsu Yanada, Tadaharu Kanie, Akihiro Tomita, Yoshiki Akatsuka, Masataka Okamoto, Toshiki Kameyama, Akila Mayeda, Nobuhiko Emi
    International Journal of Hematology 108(2) 208-212 2018年8月1日  査読有り
  • 飴本 剛之介, 亀山 俊樹, 日下 守, 前田 明, 白木 良一
    日本泌尿器科学会総会 106回 PP1-023 2018年4月  
  • 飴本剛之介, 亀山俊樹, 日下守, 前田明, 白木良一
    藤田学園医学会誌 42(1) 37-40 2018年  査読有り
  • Izumo N, Ishibashi Y, Ono Y, Toho M, Sumino A, Kameyama T, Morikawa T, Shiba Y, Watanabe Y, Manabe T
    Global Drugs and Therapeutics. 2(5) 1-5 2017年9月  査読有り
  • Hitoshi Suzuki, Yoshitsugu Aoki, Toshiki Kameyama, Takashi Saito, Satoru Masuda, Jun Tanihata, Tetsuya Nagata, Akila Mayeda, Shin'ichi Takeda, Toshifumi Tsukahara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 17(10) 2016年10月  査読有り
  • Lshibashi, Y., Lzumo, N., Lwata, K., Morikawa, T., Kameyama, T., Watanabe, Y., Manabe, T., Matsuzaki, H.
    Journal of Brain Science 46 5-19 2016年6月  査読有り
  • Abe A, Mizuta S, Okamoto A, Yamamoto Y, Kameyama T, Mayeda A, Emi N
    International journal of laboratory hematology 38(2) e15-e18 2016年4月  査読有り
  • Akihiro Abe, Yukiya Yamamoto, Sachiko Iba, Tadaharu Kanie, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma, Masamitsu Yanada, Satoko Morishima, Shuichi Mizuta, Yoshiki Akatsuka, Masataka Okamoto, Toshiki Kameyama, Akila Mayeda, Nobuhiko Emi
    Genes Chromosomes and Cancer 55(3) 242-250 2016年3月1日  査読有り
  • Akihiro Abe, Yukiya Yamamoto, Sachiko Iba, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma, Masamitsu Yanada, Satoko Morishima, Tadaharu Kanie, Motohiro Tsuzuki, Yoshiki Akatsuka, Shuichi Mizuta, Masataka Okamoto, Toshiki Kameyama, Akila Mayeda, Nobuhiko Emi
    Cytogenetic and Genome Research 146(4) 279-284 2015年12月1日  査読有り
  • 石瀬 仁司, 白木 良一, 西野 将, 竹中 政史, 糠谷 拓尚, 深谷 孝介, 佐々木 ひと美, 日下 守, 石川 清仁, 星長 清隆, 亀山 俊樹, 前田 明
    日本泌尿器科学会総会 103回 708-708 2015年4月  
  • Yuki Miyatake, Shinsuke Matsuzaki, Manabu Taniguchi, Hironori Takamura, Kohei Yamada, Tsuyoshi Hattori, Toshiki Kameyama, Takayuki Manabe, Masaya Tohyama, Taiichi Katayama
    Journal of brain science 45 5-34 2015年3月  査読有り
    Alternative splicing (AS) contributes to the generation of distinct mRNAs from the same pre-mRNA. This mechanism is highly conserved in eukaryotes and yields proteomic diversity. Furthermore, AS can be tissue- and developmental stage-specific and is an important process in the development of the central nervous system. Although these features suggest that AS variants contribute the complexity of the brain, the characteristics of most AS variants are unclear. Therefore, it is important to identify and examine novel AS variants in neuronal tissues to fully understand neuronal functions. We have identified a novel AS variant of murine disrupted in schizophrenia 1 (Disc1), a neural developmental gene. This variant lacks exon 2 and is named 'ΔE2'. We also show differences in the expression levels and localization patterns between ΔE2 and full length Disc1 (FL) in the murine brain. Differences in the subcellular localization patterns of both isoforms in cultured SK-N-SH cells suggest that ΔE2 has different functions compared with those of FL. Further functional analysis of ΔE2 may indicate additional roles of Disc1, and may further our understanding of the developmental mechanisms for neurodevelopmental disorders such as schizophrenia.
  • Kazuki Terada, Nobuo Izumo, Biora Suzuki, Yoshiharu Karube, Tomomi Morikawa, Yukiko Ishibashi, Toshiki Kameyama, Koji Chiba, Noriko Sasaki, Keiko Iwata, Hideo Matsuzaki, Takayuki Manabe
    NEUROCHEMISTRY INTERNATIONAL 69 9-13 2014年4月  査読有り
  • Fumio Matsushita, Toshiki Kameyama, Yuzo Kadokawa, Tohru Marunouchi
    DEVELOPMENTAL DYNAMICS 243(4) 588-600 2014年4月  査読有り責任著者
  • Hitoshi Suzuki, Toshiki Kameyama, Kenji Ohe, Toshifumi Tsukahara, Akila Mayeda
    FEBS Letters 587(6) 555-561 2013年3月18日  査読有り
  • Hitoshi Suzuki, Toshiki Kameyama, Kenji Ohe, Toshifumi Tsukahara, Akila Mayeda
    FEBS LETTERS 587(6) 555-561 2013年3月  査読有り
  • Toshiki Kameyama, Hitoshi Suzuki, Akila Mayeda
    NUCLEIC ACIDS RESEARCH 40(16) 7896-7906 2012年9月  査読有り
  • Toshiki Kameyama, Fumio Matsushita, Yuzo Kadokawa, Tohru Marunouchi
    NEUROSCIENCE LETTERS 497(2) 74-79 2011年6月  査読有り筆頭著者責任著者
  • F Matsushita, T Kameyama, T Marunouchi
    MECHANISMS OF DEVELOPMENT 118(1-2) 209-213 2002年10月  査読有り
  • Y Murakami, F Suto, M Shimizu, T Shinoda, T Kameyama, H Fujisawa
    DEVELOPMENTAL DYNAMICS 220(3) 246-258 2001年3月  査読有り
  • H Fujisawa, K Ohta, T Kameyama, Y Murakami
    DEVELOPMENTAL NEUROSCIENCE 19(1) 101-105 1997年1月  査読有り
  • T Kameyama, Y Murakami, F Suto, A Kawakami, S Takagi, T Hirata, H Fujisawa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 226(2) 396-402 1996年9月  査読有り
  • T Kameyama, Y Murakami, F Suto, A Kawakami, S Takagi, T Hirata, H Fujisawa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 226(2) 524-529 1996年9月  査読有り
  • H IDE, N WADA, T KAMEYAMA, K UCHIYAMA
    LIMB DEVELOPMENT AND REGENERATION, PT B 383 475-484 1993年  査読有り

MISC

 31

書籍等出版物

 2

講演・口頭発表等

 15

担当経験のある科目(授業)

 16
  • 2025年9月 - 現在
    生命科学  (藤田医科大学医学部)
  • 2024年4月 - 現在
    病態生理学特論  (藤田医科大学大学院保健学研究科保健学専攻看護学領域 急性期・周術期分野)
  • 2024年4月 - 現在
    人体機能学概論  (藤田医科大学大学院医学研究科博士前期課程)
  • 2022年4月 - 現在
    遺伝学  (中京学院大学看護学部)
  • 2022年4月 - 現在
    医学教育入門  (藤田医科大学医学部医学科)

共同研究・競争的資金等の研究課題

 18

学術貢献活動

 3

メディア報道

 1

その他

 3